Filing Flows › Charles River Laboratories International (CRL) › Q2 2026 › vs Q2 2025
Charles River Laboratories International (CRL) Q2 2026 vs Q2 2025 (year over year)
Charles River Laboratories International's revenue fell $28.1M (-3%) from $1.0B in Q2 2025 to $1.0B in Q2 2026. The biggest changes: Manufacturing −$12.7M (-6%); DSA −$11.5M (-2%); RMS −$3.8M (-2%).
Charles River Laboratories International, Q2 2026: revenue $1.0B (-3% year over year), operating margin 11.9%, net loss $760K, operating cash flow $180M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 14.8% | 16.4% | -1.6 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| DSA | $607M | $618M | −$11.5M | -2% |
| RMS | $209M | $213M | −$3.8M | -2% |
| Manufacturing | $188M | $201M | −$12.7M | -6% |
| Revenue | $1.0B | $1.0B | −$28.1M | -3% |
| Net loss | $760K | −$52.7M | $53.5M | — |
| Costs & expenses | $1.0B | $1.0B | −$27.3M | -3% |
| Operating costs | $884M | $932M | −$47.8M | -5% |
| Interest & other, net | $66.7M | $28.7M | $38.0M | +132% |
| Income tax | $53.9M | $18.7M | $35.2M | +188% |
| SG&A | $229M | $192M | $37.3M | +19% |
| Other operating costs | $655M | $740M | −$85.2M | -12% |
| Operating cash sources | $180M | $152M | $28.6M | +19% |
| Depreciation & amortization | $67.3M | $120M | −$52.2M | -44% |
| Share-based compensation | $19.8M | $17.0M | $2.7M | +16% |
| Working capital & other | $93.4M | $15.4M | $78.1M | +508% |
| Net loss absorbed | $760K | −$52.7M | $53.5M | — |
| Operating cash flow | $180M | $205M | −$24.9M | -12% |
| Free cash flow (OCF − capex) | $149M | $169M | −$20.7M | -12% |
| Capital expenditures | $31.1M | $35.3M | −$4.2M | -12% |
Questions
How much did Charles River Laboratories International's revenue grow year over year in Q2 2026?
Charles River Laboratories International's revenue fell $28.1M (-3%) from $1.0B in Q2 2025 to $1.0B in Q2 2026.
What drove Charles River Laboratories International's revenue change in Q2 2026?
Manufacturing −$12.7M (-6%); DSA −$11.5M (-2%); RMS −$3.8M (-2%).